Crinetics Pharmaceuticals, Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -1,021.73%-445.43%-1,110.46%-4,222.30%-104,171.83%-9,976.35%-3,452.92%-5,212.36%-28,625.51%
EBIT Margin -1,026.15%-446.31%-1,182.45%-4,512.32%-105,567.61%-9,990.91%-3,544.06%-5,547.17%-32,613.47%
EBITDA Margin -1,021.90%-447.78%-1,114.25%-4,219.20%-104,133.80%-10,023.01%-3,535.30%-5,223.55%-28,722.04%
Operating Margin -1,026.15%-446.31%-1,182.45%-4,512.32%-105,567.61%-9,990.91%-3,544.06%-5,547.17%-32,613.47%
Net Margin -1,021.73%-445.43%-1,110.46%-4,222.30%-104,171.83%-9,976.35%-3,452.92%-5,212.36%-28,625.51%
FCF Margin -960.61%-478.39%-845.06%-3,929.00%-87,623.94%-8,258.26%-2,466.98%-4,261.03%-22,118.77%
Efficiency
Assets Average 93.51M150.90M156.91M267.23M351.60M493.76M1,034.97M
Equity Average 72.60M138.68M143.03M250.43M324.14M427.72M931.96M
Invested Capital -15.02M160.22M117.14M168.92M331.94M316.33M539.11M1,324.81M
Asset Utilization Ratio 0.030.010.000.000.010.010.00
Leverage & Solvency
Interest Coverage Ratio -549.45-0.00M
Equity Ratio -0.960.930.900.920.950.900.850.92
Times Interest Earned -549.45-0.00M
Valuation
Enterprise Value -14.19M556.99M489.35M293.65M1,015.26M649.01M1,816.86M3,387.61M
Market Capitalization 720.87M607.74M464.53M1,349.47M984.73M2,376.72M4,741.67M
Return Ratios
Return on Sales -10.22%-4.45%-11.10%-42.22%-99.76%-34.53%-52.12%-286.26%
Return on Capital Employed -0.34%-0.38%-0.51%-0.43%-0.52%-0.49%-0.35%
Return on Assets -0.29%-0.33%-0.47%-0.40%-0.47%-0.42%-0.29%
Return on Equity -0.37%-0.36%-0.52%-0.43%-0.50%-0.49%-0.32%